Scarica l'app Stockscreener
1.02
0.97%
-0.01
Dopo l'orario di chiusura:
1.02
Precedente Chiudi:
$1.03
Aprire:
$1.0499
Volume 24 ore:
114.20K
Relative Volume:
0.74
Capitalizzazione di mercato:
$42.86M
Reddito:
-
Utile/perdita netta:
$-32.00M
Rapporto P/E:
-0.672
EPS:
-1.5178
Flusso di cassa netto:
$-4.66M
1 W Prestazione:
+0.99%
1M Prestazione:
-8.11%
6M Prestazione:
-33.33%
1 anno Prestazione:
-12.82%
Intervallo 1D:
$1.01
$1.05
Intervallo di 1 settimana:
$1.00
$1.075
Portata 52W:
$0.90
$2.45
Mira Pharmaceuticals Inc Stock (MIRA) Company Profile
Nome
Mira Pharmaceuticals Inc
Settore
Industria
Telefono
813-369-5150
Indirizzo
1200 BRICKELL AVENUE, MIAMI
Compare MIRA vs LLY, JNJ, ABBV, AZN, MRK
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
MIRA
Mira Pharmaceuticals Inc
|
1.02 | 43.28M | 0 | -32.00M | -4.66M | -1.5178 |
LLY
Lilly Eli Co
|
988.87 | 863.14B | 72.25B | 25.28B | 10.37B | 27.78 |
JNJ
Johnson Johnson
|
225.55 | 539.70B | 96.36B | 21.04B | 17.80B | 8.6488 |
ABBV
Abbvie Inc
|
206.11 | 368.19B | 62.82B | 3.62B | 17.82B | 2.0331 |
AZN
Astrazeneca Plc
|
181.24 | 284.52B | 60.48B | 10.40B | 8.05B | 3.3297 |
MRK
Merck Co Inc
|
113.15 | 279.37B | 65.59B | 8.93B | 12.36B | 3.5532 |
Mira Pharmaceuticals Inc Borsa (MIRA) Ultime notizie
What's going on with MIRA Pharma stock Tuesday? - MSN
MIRA Pharmaceuticals (MIRA) Top Loser | Q3 2025: Profit SurprisesPost Earnings - UBND thành phố Hải Phòng
Should I buy MIRA Pharmaceuticals (MIRA) stock right now | Q3 2025: EPS Exceeds ExpectationsMargin of Safety - UBND thành phố Hải Phòng
MIRA Pharmaceuticals (MIRA) Stock: Momentum Analysis (Momentum Building) 2026-04-16Low Volatility Stocks - Xã Vĩnh Công
Stock List: Research Stocks from Around the World - GuruFocus
MIRA Stock Price, Quote & Chart | MIRA PHARMACEUTICALS INC (NASDAQ:MIRA) - ChartMill
Aug Summary: How does MIRA Pharmaceuticals Inc compare to its peersWeekly Investment Recap & AI Driven Stock Movement Reports - baoquankhu1.vn
Is MIRA Pharmaceuticals (MIRA) Stock Good for Active Traders | Price at $1.03, Down 4.63%Elite Trading Signals - Newser
MIRA Pharmaceuticals, Inc.: Fundamental Analysis and Financial Ratings | K6S | US60458C1045 - marketscreener.com
MIRA Pharmaceuticals : Investor Presentation - marketscreener.com
MIRA Technical Analysis & Stock Price Forecast - Intellectia AI
MIRA completes Phase 1 trial of oral NMDA drug Ketamir-2 - Investing.com
MIRA Stock Analysis: MIRA Pharmaceuticals Inc. rises 4.72 pct to hold 1.11 level - Newser
MIRA Pharmaceuticals Inc. (MIRA) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Investment Report: How does MIRA Pharmaceuticals Inc compare to its peersPortfolio Gains Report & Weekly High Return Stock Opportunities - baoquankhu1.vn
MIRA Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Aminov Erez - 富途牛牛
Mira Pharmaceuticals Inc (K6S.MU) stock price, news, quote and history - Yahoo Finance UK
MIRA Pharmaceuticals (MIRA) CEO granted 83,500 RSUs - Stock Titan
MIRA Should I Buy - Intellectia AI
Cash strain and trial progress at MIRA Pharmaceuticals (NASDAQ: MIRA) - Stock Titan
Mira Pharmaceuticals 10-K: $— Revenue, $(1.35) EPS, $(10.44)M Net Loss - tradingview.com
MIRA Pharmaceuticals | 10-K: FY2025 Annual Report - Moomoo
MIRA Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
MIRA Pharmaceuticals, Inc. Auditor Raises 'Going Concern' Doubt - marketscreener.com
Institution Moves: Can MIRA Pharmaceuticals Inc deliver alphaWeekly Gains Summary & Daily Volume Surge Trade Alerts - baoquankhu1.vn
Analyst Downgrade: What are MIRA Pharmaceuticals Incs recent SEC filings showing2026 WrapUp & Community Shared Stock Ideas - baoquankhu1.vn
Retail Surge: Is MIRA Pharmaceuticals Inc a strong growth stockMarket Growth Report & Weekly Setup with High ROI Potential - baoquankhu1.vn
MIRA Pharmaceuticals, Inc.Common Stock (NQ:MIRA) - FinancialContent
What's Going On With MIRA Pharma Stock Tuesday? - Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
MIRA’s Mira-55 shows no CNS side effects in preclinical tests By Investing.com - Investing.com India
MIRA Pharmaceuticals Highlights Encouraging Safety Data for Mira-55 - TipRanks
MIRA Pharmaceuticals Reports Mira-55 Shows No THC- or Rimonabant-Associated CNS Side Effects in Preclinical Studies - The Desert Sun
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
Mira Pharmaceuticals, Inc. Announces Positive Preclinical Results for Mira-55, a Non-Opioid Pain and Anxiety Treatment - Minichart
Mira Pharmaceuticals reports preclinical results for Mira-55 with no observed THC- or rimonabant-like CNS side effects - Investing.com India
MIRA’s Mira-55 shows no CNS side effects in preclinical tests - investing.com
MIRA pain drug showed morphine-like relief without THC-like effects - Stock Titan
MIRA Pharmaceuticals (MIRA) posts Mira-55 CNS and pain preclinical data - Stock Titan
Aug EndMonth: What is the Moat Score of MIRA Pharmaceuticals Inc2026 Macro Moves & Weekly Return Optimization Plans - baoquankhu1.vn
Momentum Shift: Can MIRA Pharmaceuticals Inc maintain its current growth rateRate Cut & Precise Swing Trade Alerts - baoquankhu1.vn
Macro Review: Can MIRA Pharmaceuticals Inc maintain its current growth rateTrade Ideas & Reliable Price Breakout Signals - baoquankhu1.vn
Dividend Watch: Can MIRA Pharmaceuticals Inc deliver alphaQuarterly Profit Report & Advanced Swing Trade Entry Plans - baoquankhu1.vn
Short Interest in MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) Drops By 13.9% - MarketBeat
Mira Pharmaceuticals Inc Azioni (MIRA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.57%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):